个性化文献订阅>文章检索

文章名     作者     期刊名     摘要     卷     期         如果没有找到您所需要的文献，请点击 ——此处申请     共6条记录   AN OVERVIEW OF SALSALATE AS A POTENTIAL ANTIDIABETIC THERAPY [作者：Desouza, CV,期刊：Drugs of today, 页码：847-853 , 文章类型： Review，,卷期：2010年46-11] The incidence of type 2 diabetes is increasing at an alarming rate throughout the world. This is in large part due to the increase in obesity and the aging of the population. Therefore, new medications to combat type 2 d... PANCRELIPASE FOR PANCREATIC DISORDERS: AN UPDATE [作者：Dhanasekaran, R; Toskes, PP,期刊：Drugs of today, 页码：855-866 , 文章类型： Review，,卷期：2010年46-11] Pancrelipase is a porcine pancreatic extract which contains the digestive enzymes lipases, proteases and amylases. In patients with pancreatic exocrine insufficiency (PEI) from conditions such as chronic pancreatitis, pa... REPLACEMENT THERAPY WITH C1 ESTERASE INHIBITORS FOR HEREDITARY ANGIOEDEMA [作者：Cicardi, P; Zanichelli, A,期刊：Drugs of today, 页码：867-874 , 文章类型： Review，,卷期：2010年46-11] Angioedema due to hereditary Cl inhibitor deficiency (HAE) is a highly disabling and potentially lethal disease with an estimated prevalence of 1:50,000 in the general population worldwide. Treatment of this condition by... EZOGABINE: A NOVEL ANTIEPILEPTIC AS ADJUNCTIVE THERAPY FOR PARTIAL ONSET SEIZURES [作者：Owen, RT,期刊：Drugs of today, 页码：815-822 , 文章类型： Article，,卷期：2010年46-11] Ezogabine (retigabine) is a novel antiepileptic agent which primarily acts to stabilize neuronal potassium-gated ion channels. Currently no other marketed antiepileptic drugs (AEDs) share this mode of action. Ezogabine's... ROFLUMILAST FOR COPD [作者：Izquierdo, JL; Aparicio, J,期刊：Drugs of today, 页码：823-831 , 文章类型： Article，,卷期：2010年46-11] Patients with chronic obstructive pulmonary disease (CORD) and chronic bronchitis have a reduction in lung function and a higher risk of suffering exacerbations, which result in a deterioration in their quality of life, ... TEMOZOLOMIDE: EXPANDING ITS ROLE IN BRAIN CANCER [作者：Mrugala, MM; Adair, J; Kiem, HP,期刊：Drugs of today, 页码：833-846 , 文章类型： Article，,卷期：2010年46-11] Management of central nervous system (CNS) malignancies continues to be a therapeutic challenge. Both primary and secondary (metastatic) CNS tumors are frequently resistant to commonly used chemotherapeutic agents. Surge...